鉴定了二进制性发育不良症中潜在的非侵入性生物标志物
Chiara Paganini1, Ricki S Carroll2, Chiara Gramegna Tota1
1Department of Molecular Medicine, Unit of Biochemistry, University of Pavia, Pavia, Italy.
Bone
|July 16, 2023
概括
探索了灾难性发育不良症 (DTD) 的生物标志物. 在DTD患者中观察到尿液中的葡萄糖氨基糖 (GAG) 低硫化和较低的原X标志物 (CXM) 水平,这表明监测治疗疗效的潜力.
科学领域:
- 生物化学 生物化学
- 遗传学 是一个遗传学.
- 骨发育不良症 骨发育不良症
背景情况:
- 灾难性发育不良 (DTD) 是一种严重的骨疾病,由SLC26A2基因变异引起,影响硫酸盐运输和糖氨基甘油 (GAG) 硫化.
- 正在探索DTD的药理疗法,需要可靠的非侵入性生物标志物来评估临床试验中的治疗疗效.
研究的目的:
- 调查尿液GAG硫化模式和血液原X标志物 (CXM) 水平作为DTD患者潜在的非侵入性生物标志物.
主要方法:
- 在尿液中分离出GAG,并使用HPLC在酶消化后分析ondroitin硫酸脱糖化合物组成.
- 在干燥的血斑中测量了原X标志物 (CXM) 水平.
- 来自DTD患者的结果与年龄匹配的对照组进行了比较.
主要成果:
- DTD患者表现出尿液GAG的低硫化,与临床严重程度和特定的SLC26A2变异相关.
- 大多数DTD患者呈现的CXM水平低于正常水平,尽管这个标记因年龄,性别和生长速度而变化.
结论:
- 尿液GAG硫化和CXM水平显示为DTD的非侵入性生物标志物具有前途.
- 这些生物标志物可以潜在地监测疾病的各个方面,包括GAG代谢和内分泌骨化,有助于未来的治疗评估.
更多相关视频
12:12Echocardiographic Approaches and Protocols for Comprehensive Phenotypic Characterization of Valvular Heart Disease in Mice
Published on: February 14, 2017
16.1K
09:43Multimodal Study of Murine Cardiovascular Remodeling: Four-Dimensional Ultrasound and Mass Spectrometry Imaging
Published on: January 10, 2025
1.3K
相关概念视频
Cardiomyopathy III: Hypertrophic Cardiomyopathy
16
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
16
Mitral Stenosis II: Clinical features and Diagnostic Tests
23
Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
23
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
38
The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
38
